FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track 
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions 
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling 
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy 
OpenAI Explores Massive Funding Round at $750 Billion Valuation 
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group 
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
CAMPBELL, Calif., Aug. 07, 2017 -- Saama Technologies, Inc., a leading big data and advanced analytics solutions company, announced that Christine Poon, a life sciences industry luminary, is going to be a member of their Board of Advisors.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/5196b4b9-477d-4819-bbfd-1495c0a56b3e
Christine Poon is the former Vice Chairman of Johnson & Johnson’s Board of Directors and former Worldwide Chairman of its Medicines & Nutritionals division. Under her leadership, Johnson & Johnson’s pharmaceutical business went through its fastest growth period, becoming the fourth biggest pharmaceutical company in the world. Prior to Johnson & Johnson, Christine was with Bristol-Myers Squibb for 15 years. Ms. Poon has degrees in Biology from St. Louis University and Northwestern as well as an MBA in Finance from the Boston University.
Christine’s business skills and passion for improving lives are held in high regard by the entire life sciences industry.
Christine said, “I look forward to taking on new challenges and discovering opportunities, especially those that involve keeping the society healthy by developing solutions powered by science and technology. Every day that a life-saving drug is delayed costs us precious lives. When we use technology to put the data we have to good use, especially to give us the necessary insights quickly, we not only get that life-saving drug to the marker faster, but also produce a better product. This is why I am happy to be associated with Saama and look forward to contributing to their growing set of data analytics offering for the Life Sciences industry.”
Founder and CEO of Saama Technologies, Suresh Katta said, “We are delighted to have Christine Poon on board. She brings deep knowledge of the industry and is sure to be an asset for us from both strategic and operational aspects. She is passionate about finding technology solutions that can advance the efforts of the life sciences industry. We welcome her perspective and are looking forward to working with someone of her stature.”
With Christine Poon on board, Saama sharpens its life sciences focus and dials up its commitment for providing data management and analytics solutions to organizations by turning their data into a source of actionable intelligence and business insights.
About Saama
Saama Technologies is the advanced data and analytics company delivering actionable business insights for life sciences, and the Global 2000. We are singularly focused on driving fast, flexible, impactful business outcomes for our clients through data and analytics. Our unique “hybrid” approach integrates focused solutions and expertise across the life sciences domain, business consulting, data science, automated data management and big data technologies. We blend manual and disconnected initiatives into a well-aligned roadmap facilitating the client’s journey from strategy through solution implementation.
Media Contact Crystal Black [email protected] 408-426-3935
